Shames, D. S., & Minna, J. D. (2008). IP6K2 is a client for HSP90 and a target for cancer therapeutics development. National Academy of Sciences.
Citação norma ChicagoShames, David S., and John D. Minna. IP6K2 Is a Client for HSP90 and a Target for Cancer Therapeutics Development. National Academy of Sciences, 2008.
ציטוט MLAShames, David S., and John D. Minna. IP6K2 Is a Client for HSP90 and a Target for Cancer Therapeutics Development. National Academy of Sciences, 2008.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.